EUR 0.25
(0.79%)
Year | Operating Income | Operating Income Growth |
---|---|---|
2022 | -417.66 Thousand EUR | 99.65% |
2021 | -249.41 Thousand EUR | 62.74% |
2020 | -669.45 Thousand EUR | 31.88% |
2019 | -982.78 Thousand EUR | -120799.36% |
2018 | -812.89 EUR | 23.21% |
2017 | -1058.63 EUR | -218.39% |
2016 | 894.23 EUR | 269.49% |
2015 | -527.60 EUR | 15.66% |
2014 | -625.53 EUR | 99.95% |
2013 | -1.22 Million EUR | 22.75% |
2012 | -1.59 Million EUR | -23.41% |
2011 | -1.28 Million EUR | 27.33% |
2010 | -1.77 Million EUR | -0.11% |
2009 | -1.77 Million EUR | 8.05% |
2008 | -1.92 Million EUR | -21.8% |
2007 | -1.58 Million EUR | 0.0% |
Year | Operating Income | Operating Income Growth |
---|---|---|
2023 Q2 | - EUR | 0.0% |
2022 Q2 | -232.03 Thousand EUR | 0.0% |
2022 Q4 | -667.87 EUR | 0.0% |
2022 FY | -866.71 EUR | 99.65% |
2021 Q2 | -100.09 Thousand EUR | 0.0% |
2021 Q4 | -148.93 Thousand EUR | 0.0% |
2021 FY | -249.41 Thousand EUR | 62.74% |
2020 FY | -669.45 Thousand EUR | 31.88% |
2020 Q2 | -310.41 Thousand EUR | 0.0% |
2020 Q4 | -359.04 Thousand EUR | 0.0% |
2019 Q2 | -430.3 Thousand EUR | 0.0% |
2019 FY | -982.78 Thousand EUR | -120799.36% |
2019 Q4 | -552.48 Thousand EUR | 0.0% |
2018 FY | -812.89 EUR | 23.21% |
2018 Q4 | -474.54 EUR | 0.0% |
2018 Q2 | -338.35 EUR | 0.0% |
2017 Q2 | -408.06 EUR | 0.0% |
2017 Q4 | -650.57 EUR | 0.0% |
2017 FY | -1058.63 EUR | -218.39% |
2016 FY | 894.23 EUR | 269.49% |
2016 Q4 | 1062.11 EUR | 0.0% |
2016 Q2 | -167.88 EUR | 0.0% |
2015 Q4 | -274.66 EUR | 0.0% |
2015 FY | -527.60 EUR | 15.66% |
2015 Q2 | -252.94 EUR | 0.0% |
2014 Q4 | -359.12 EUR | 0.0% |
2014 Q2 | -266.42 EUR | 0.0% |
2014 FY | -625.53 EUR | 99.95% |
2013 Q3 | -307.05 Thousand EUR | -41134.22% |
2013 Q4 | -406.61 EUR | 99.87% |
2013 Q2 | -744.66 EUR | 99.76% |
2013 FY | -1.22 Million EUR | 22.75% |
2013 Q1 | -307.05 Thousand EUR | 0.0% |
2012 Q3 | -396.87 Thousand EUR | 0.0% |
2012 FY | -1.59 Million EUR | -23.41% |
2012 Q1 | -396.87 Thousand EUR | 0.0% |
2012 Q2 | -396.87 Thousand EUR | 0.0% |
2011 Q3 | -324.76 Thousand EUR | 0.0% |
2011 Q2 | -324.76 Thousand EUR | 0.0% |
2011 Q1 | -324.76 Thousand EUR | 0.0% |
2011 FY | -1.28 Million EUR | 27.33% |
2010 Q2 | -339.8 Thousand EUR | 0.0% |
2010 Q3 | -339.8 Thousand EUR | 0.0% |
2010 Q1 | -339.8 Thousand EUR | 0.0% |
2010 FY | -1.77 Million EUR | -0.11% |
2009 FY | -1.77 Million EUR | 8.05% |
2009 Q3 | -532.63 Thousand EUR | 0.0% |
2009 Q2 | -532.63 Thousand EUR | 0.0% |
2009 Q1 | -532.63 Thousand EUR | 0.0% |
2008 Q1 | -723.57 Thousand EUR | 0.0% |
2008 Q2 | -723.57 Thousand EUR | 0.0% |
2008 Q3 | -723.57 Thousand EUR | 0.0% |
2008 FY | -1.92 Million EUR | -21.8% |
2007 Q2 | -426.84 Thousand EUR | 0.0% |
2007 Q1 | -426.84 Thousand EUR | 0.0% |
2007 Q3 | -426.84 Thousand EUR | 0.0% |
2007 FY | -1.58 Million EUR | 0.0% |
Name | Operating Income | Operating Income Difference |
---|---|---|
aap Implantate AG | -5.16 Million EUR | 91.92% |
Drägerwerk AG & Co. KGaA | 171.18 Million EUR | 100.244% |
Drägerwerk AG & Co. KGaA | 171.18 Million EUR | 100.244% |
Eckert & Ziegler Strahlen- und Medizintechnik AG | 46.99 Million EUR | 100.889% |
Geratherm Medical AG | 2.21 Million EUR | 118.82% |
Koninklijke Philips N.V. | -115 Million EUR | 99.637% |
Stratec SE | 22.88 Million EUR | 101.825% |
Siemens Healthineers AG | 2.86 Billion EUR | 100.015% |